- Report
- September 2026
- 185 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 185 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 192 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 187 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 184 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 189 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 185 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 184 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- May 2026
- 140 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- March 2026
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- November 2025
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- April 2026
- 146 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- April 2026
- 138 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- April 2026
- 138 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- January 2026
- 292 Pages
Global
From €2298EUR$2,500USD£1,954GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- April 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more